Junqiang Ding
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 4
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Yanzhi Song (12 shared papers)Xinrong Liu (9 shared papers)Xihui Gao (7 shared papers)Xiaoxiao Liu (5 shared papers)Yihui Deng (9 shared papers)Wuyuan Lu (2 shared papers)Chongbing Liao (1 shared paper)Mingqi Liu (5 shared papers)
- Journals
- International Journal of Pharmaceutics (2 papers)Molecular Pharmaceutics (2 papers)Advanced Drug Delivery Reviews (1 paper)ACS Biomaterials Science & Engineering (1 paper)Nano Today (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Junqiang Ding
18 papers receiving 530 citations
Peers
Comparison fields: 5 of 77
- Microbiology 79
- Biomaterials 162
- Immunology 160
- Pharmaceutical Science 27
- Molecular Biology 227
Countries citing papers authored by Junqiang Ding
This map shows the geographic impact of Junqiang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqiang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqiang Ding more than expected).
Fields of papers citing papers by Junqiang Ding
This network shows the impact of papers produced by Junqiang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqiang Ding. The network helps show where Junqiang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Junqiang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 126 | |
| 2 | 2022 | 78 | |
| 3 | 2021 | 55 | |
| 4 | 2019 | 43 | |
| 5 | 2019 | 37 | |
| 6 | 2021 | 27 | |
| 7 | 2018 | 26 | |
| 8 | 2021 | 25 | |
| 9 | 2018 | 21 | |
| 10 | 2022 | 19 | |
| 11 | 2018 | 16 | |
| 12 | 2024 | 13 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2019 | 10 | |
| 16 | 2020 | 7 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 0 |
About Junqiang Ding
Junqiang Ding is a scholar working on Immunology, Biomaterials, Biotechnology, Immunology and Allergy and Pharmaceutical Science, having authored 19 papers that have together received 532 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Immunotherapy and Immune Responses (6 papers), Nanoplatforms for cancer theranostics (6 papers), Virus-based gene therapy research (4 papers), Immune cells in cancer (4 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Microbiology (79 citations), Biomaterials (162 citations), Immunology (160 citations), Pharmaceutical Science (27 citations) and Molecular Biology (227 citations). Junqiang Ding has collaborated with scholars based in China and South Korea. Frequent co-authors include Yanzhi Song, Xinrong Liu, Xihui Gao, Xiaoxiao Liu, Yihui Deng, Wuyuan Lu, Chongbing Liao, Mingqi Liu, Yuqing Su and Yawei Hu. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Advanced Drug Delivery Reviews, ACS Biomaterials Science & Engineering and Nano Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.